Not greater than 65% we wanted to see but not far from it. I would think light selloff today as people wanted an absolute rather than research project with encouraging data.
Couple interesting points
Jumped from 1 month to 6months before 1st out break. This is actually really interesting.
Phase 2b going ahead which means wayne and frazer believe it can improve with optimisation of techniques and larger sample size.
Big difference between in results between how injected and where.
Overall i would liked to have seen higher numbers but im not discouraged either. Hsv2 is a nasty little bastard to prevent and treat and demoralizing when you habe an outbreak so reduction in outbreaks is psychologically important.
Im still in this for the adapt cc platform regardless and cant get enough shares just on that alone. Having vax slowly simmering in the background is fine by me
Oh yeah - hpv sounded very promising - especially the collaboration. Long term though.
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-51
-
- There are more pages in this discussion • 300 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.49 |
Change
0.490(4.08%) |
Mkt cap ! $264.0M |
Open | High | Low | Value | Volume |
$12.11 | $12.49 | $11.50 | $155.8K | 13.16K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 175 | $11.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.49 | 77 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 772 | 11.600 |
2 | 2000 | 11.500 |
1 | 80 | 11.250 |
1 | 500 | 11.050 |
2 | 600 | 11.000 |
Price($) | Vol. | No. |
---|---|---|
12.490 | 77 | 1 |
12.500 | 56 | 1 |
12.520 | 500 | 1 |
12.850 | 99 | 1 |
13.300 | 200 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |